Back to all bills
HR 1227119th CongressIn Committee
Alternatives to PAIN Act
Introduced: Feb 12, 2025
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1] (R-Iowa)
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Alternatives to PAIN Act ensures Medicare Part D beneficiaries have appropriate access to non-opioid pain management drugs without cost barriers.
Key Points
- 1Eliminates deductibles for qualifying non-opioid pain management drugs
- 2Places qualifying drugs on lowest cost-sharing tier
- 3Prohibits step therapy requiring opioids before non-opioid alternatives
- 4Prohibits prior authorization requirements for qualifying drugs
- 5Applies to plan years beginning January 1, 2026
- 6Defines qualifying drugs as FDA-approved for acute pain without opioid receptors
Impact Areas
Medicare Part D beneficiariesNon-opioid pain management drug accessOpioid crisis preventionPharmaceutical coverage policiesPain management treatment optionsMedicare prescription drug program
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025